ProtoKinetix, Inc.

General ticker "PKTX" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $3.5M

ProtoKinetix, Inc. does not follow the US Stock Market performance with the rate: -39.9%.

Estimated limits based on current volatility of 1.2%: low 0.01$, high 0.01$

Factors to consider:

  • Current price 19.4% below estimated low
  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [0.01$, 0.04$]
  • 2024-12-30 to 2025-12-30 estimated range: [0.01$, 0.04$]

Financial Metrics affecting the PKTX estimates:

  • Negative: Non-GAAP EPS, $ of 0 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Positive: Inventory ratio change, % of 0 <= 0
  • Negative: Operating cash flow per share per price, % of -33.18 <= 2.35
  • Negative: Industry earnings per price (median), % of -26.04 <= 1.31

Similar symbols

Short-term PKTX quotes

Long-term PKTX plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $2.33MM $1.91MM $0.42MM
Operating Income $-2.33MM $-1.91MM $-0.42MM
R&D Expense $0.44MM $0.45MM $0.11MM
Income(Loss) $-2.33MM $-1.91MM $-0.42MM
Profit(Loss) $-2.33MM $-1.91MM $-0.42MM
Stockholders Equity $0.35MM $0.42MM $0.44MM
Assets $0.45MM $0.46MM $0.48MM
Operating Cash Flow $-0.89MM $-0.80MM $-0.38MM
Capital expenditure $0.09MM $0.13MM $0.06MM
Investing Cash Flow $-0.09MM $-0.13MM $-0.06MM
Financing Cash Flow $0.84MM $0.90MM $0.43MM
Earnings Per Share* $-0.01 $-0.01 $-0.01

* EPS are Split Adjusted, recent splits may be reflected with a delay.